Kaskela Law LLC is investigating Rafael Holdings, Inc. (“Rafael Holdings”) (NYSE: RFL) on behalf of the company’s stockholders.
On June 21, 2021, Rafael Holdings announced that it had entered into an agreement to acquire Rafael Pharmaceuticals, Inc. (“Pharmaceuticals”) in an all-stock transaction. According to the announcement, following the proposed transaction Pharmaceuticals’ stockholders are expected to own approximately 48% of the company.
The investigation seeks to determine whether Rafael Holdings’ board of directors breached their fiduciary duties in connection with the proposed transaction to acquire Pharmaceuticals, and whether RFL stockholders have been harmed by such actions.
Rafael Holdings stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585, or by completing the information form on this page, for additional information about this investigation and their legal rights and options.